Stock listing
Prolight Diagnostics Ab
Selected listing: PRLD · NGM · SEK · SE
Prolight Diagnostics Ab (NGM:PRLD), Health Technology. Latest release Sep 7, 2026: Prolight signs supply agreement with BRAINBox valued at USD 3.9 million…
- Ticker
- NGM:PRLD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NGM
- Currency
- SEK
About Prolight Diagnostics Ab
Prolight Diagnostics Ab is a public company listed on the Swedish market under the ticker PRLD. Prolight Diagnostics focuses on developing innovative diagnostic solutions.
Latest news from Prolight Diagnostics Ab
Prolight signs supply agreement with BRAINBox valued at USD 3.9 million for the first year
September 7, 2026
Prolight Diagnostics publishes half-year report, 2026
August 27, 2026
Prolight signs GBP 2.24m development agreement with BRAINBox
July 13, 2026
Prolight receives Notice of Allowance for Psyros® patent in the US
July 8, 2026
PRLD: Psyros POC platform reached design freeze; Q1 EBIT loss -10.4 MSEK, strong liquidity post-quarter
May 26, 2026
Research Prolight Diagnostics Ab
Prolight Diagnostics Ab company profile
View the public company page for Prolight Diagnostics Ab on 6ix.
Prolight Diagnostics Ab news
Read company news and market updates connected to Prolight Diagnostics Ab.
Prolight Diagnostics Ab investor events
Find investor webinars, events, and replay context for Prolight Diagnostics Ab.